Charles Schwab Investment Management Inc Emergent Bio Solutions Inc. Transaction History
Charles Schwab Investment Management Inc
- $515 Billion
- Q3 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 2,224,727 shares of EBS stock, worth $18 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,224,727
Previous 3,166,246
29.74%
Holding current value
$18 Million
Previous $21.6 Million
13.97%
% of portfolio
0.0%
Previous 0.0%
Shares
29 transactions
Others Institutions Holding EBS
# of Institutions
160Shares Held
33.8MCall Options Held
453KPut Options Held
931K-
Black Rock Inc. New York, NY3.84MShares$31.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.4MShares$27.5 Million0.0% of portfolio
-
Marshall Wace, LLP London, X02.49MShares$20.2 Million0.03% of portfolio
-
State Street Corp Boston, MA1.91MShares$15.5 Million0.0% of portfolio
-
American Century Companies Inc Kansas City, MO1.73MShares$14 Million0.01% of portfolio
About Emergent BioSolutions Inc.
- Ticker EBS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,861,500
- Market Cap $404M
- Description
- Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...